Saw that this morning too. Conservative estimates with upside potential from growth drivers- Launch of Pennsaid 2% with partners in new markets of India and Switzerland in 4Q-2020 (topical diclofenac market in both countries ~$35 MM); • Potential approval of Pennsaid 2% in Austria, Greece, Italy and Portugal (markets where Pennsaid 1.5% has already been approved) in 2020; • Canadian
...more